Search research articles
Contact Us
Filters
Showing results (191-200 of 527) with videos related to
Page
of 53
Sort By:
Alimentary Pharmacology & Therapeutics
|
December 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 27, 2014
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing
Jen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, et al.
Plos One
|
January 29, 2021
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
Ying-Chou Huang, Chung-Feng Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences
|
February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
April 30, 2020
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment
Zu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2016
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Ming-Lung Yu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Scientific Reports
|
October 27, 2018
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
Chung-Feng Huang, Shu-Chi Wang, Wen-Tsan Chang, et al.
Medicine
|
May 1, 2004
Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis
Jung-Fa Tsai, Jen-Eing Jeng, Lee-Yea Chuang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy
Ming-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 53
Search research articles
Search
Showing results (191-200 of 527) with videos related to
Sort By:
Page
of 53
Alimentary Pharmacology & Therapeutics
|
December 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 27, 2014
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing
Jen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, et al.
Plos One
|
January 29, 2021
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
Ying-Chou Huang, Chung-Feng Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences
|
February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
Ming-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
April 30, 2020
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment
Zu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2016
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Ming-Lung Yu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Scientific Reports
|
October 27, 2018
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
Chung-Feng Huang, Shu-Chi Wang, Wen-Tsan Chang, et al.
Medicine
|
May 1, 2004
Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis
Jung-Fa Tsai, Jen-Eing Jeng, Lee-Yea Chuang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy
Ming-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Page
of 53